RG-4929

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameRG-4929
Drug Alias NameRO-5093151R-4929RG-4929
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2Glaucoma, Open-AngleGlaucoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[7] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Glaucoma, Open-AngleGlaucoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A